Vectorite Biomedical Inc. (TPEX:4170)

Vectorite Biomedical Statistics

Total Valuation

TPEX:4170 has a market cap or net worth of TWD 682.83 million. The enterprise value is 506.98 million.

Market Cap	682.83M
Enterprise Value	506.98M

Important Dates

The next estimated earnings date is Monday, April 27, 2026.

Earnings Date	Apr 27, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4170 has 43.77 million shares outstanding. The number of shares has decreased by -0.14% in one year.

Current Share Class	43.77M
Shares Outstanding	43.77M
Shares Change (YoY)	-0.14%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	17.45%
Owned by Institutions (%)	n/a
Float	32.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.06
PB Ratio	1.74
P/TBV Ratio	1.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-21.86
EV / Sales	7.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-49.93

Financial Position

The company has a current ratio of 13.46, with a Debt / Equity ratio of 0.00.

Current Ratio	13.46
Quick Ratio	12.20
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	-3,624.00

Financial Efficiency

Return on equity (ROE) is -5.73% and return on invested capital (ROIC) is -8.34%.

Return on Equity (ROE)	-5.73%
Return on Assets (ROA)	-2.65%
Return on Invested Capital (ROIC)	-8.34%
Return on Capital Employed (ROCE)	-4.51%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.16
Inventory Turnover	2.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.28% in the last 52 weeks. The beta is 0.39, so TPEX:4170's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	+10.28%
50-Day Moving Average	14.10
200-Day Moving Average	13.42
Relative Strength Index (RSI)	65.09
Average Volume (20 Days)	68,240

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4170 had revenue of TWD 67.90 million and -23.19 million in losses. Loss per share was -0.53.

Revenue	67.90M
Gross Profit	27.00M
Operating Income	-18.12M
Pretax Income	-23.22M
Net Income	-23.19M
EBITDA	-9.61M
EBIT	-18.12M
Loss Per Share	-0.53

Balance Sheet

The company has 176.70 million in cash and 473,000 in debt, with a net cash position of 176.23 million or 4.03 per share.

Cash & Cash Equivalents	176.70M
Total Debt	473,000
Net Cash	176.23M
Net Cash Per Share	4.03
Equity (Book Value)	393.46M
Book Value Per Share	8.98
Working Capital	189.47M

Cash Flow

In the last 12 months, operating cash flow was -9.29 million and capital expenditures -862,000, giving a free cash flow of -10.15 million.

Operating Cash Flow	-9.29M
Capital Expenditures	-862,000
Free Cash Flow	-10.15M
FCF Per Share	-0.23

Margins

Gross margin is 39.77%, with operating and profit margins of -26.69% and -34.16%.

Gross Margin	39.77%
Operating Margin	-26.69%
Pretax Margin	-34.20%
Profit Margin	-34.16%
EBITDA Margin	-14.16%
EBIT Margin	-26.69%
FCF Margin	n/a

Dividends & Yields

TPEX:4170 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.14%
Shareholder Yield	0.14%
Earnings Yield	-3.40%
FCF Yield	-1.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 27, 2015. It was a forward split with a ratio of 1.1005700953.

Last Split Date	Aug 27, 2015
Split Type	Forward
Split Ratio	1.1005700953

Scores

TPEX:4170 has an Altman Z-Score of 16.31 and a Piotroski F-Score of 3.

Altman Z-Score	16.31
Piotroski F-Score	3